Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
BPDO-1603
DRUG
2 trials
Sponsors
Hyundai Pharmaceutical Co., LTD.
, Hyundai Pharm
Conditions
Healthy
Moderate-to-severe Alzheimer's Disease
Phase 1
Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults
Completed
NCT05804279
Hyundai Pharm
Healthy
Start: 2022-12-28
End: 2023-03-14
Updated: 2023-04-07
Phase 3
BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease
NCT04229927
Hyundai Pharmaceutical Co., LTD.
Moderate-to-severe Alzheimer's Disease
Start: 2020-02-27
End: 2023-03-01
Target: 712
Updated: 2020-04-22